AQR Capital Management - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$341,255
-25.4%
13,483
-5.0%
0.00%0.0%
Q1 2023$457,382
+69.4%
14,200
+46.5%
0.00%0.0%
Q3 2021$270,000
-5.9%
9,6910.0%0.00%
Q2 2021$287,000
-36.6%
9,691
-40.2%
0.00%
-100.0%
Q1 2021$453,000
-9.2%
16,208
-7.9%
0.00%0.0%
Q4 2020$499,000
-1.4%
17,594
-12.6%
0.00%0.0%
Q3 2020$506,000
+55.7%
20,141
+51.4%
0.00%0.0%
Q2 2020$325,000
+61.7%
13,303
+64.5%
0.00%
Q3 2018$201,000
-44.8%
8,086
-39.0%
0.00%
Q2 2018$364,000
-10.6%
13,249
+0.3%
0.00%
Q1 2018$407,000
-11.5%
13,210
+2.8%
0.00%
Q4 2017$460,000
+60.8%
12,854
+23.7%
0.00%
Q3 2017$286,000
+74.4%
10,391
-13.9%
0.00%
Q2 2016$164,000
-38.1%
12,073
-20.5%
0.00%
Q1 2016$265,000
-38.1%
15,187
+21.3%
0.00%
-100.0%
Q4 2015$428,00012,5210.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders